Similar articles

• New recommendations for reversal of high-dose methotrexate cytotoxicity with folinic acid.

  Heldrup J, Bleyer A, Ramsey L, Schaff L, Bernhardt B, Schwartz S, Chatelut E, Hwang M, Ten C, Guscott M, Howard S. Heldrup J, et al. Cancer Chemother Pharmacol. 2025 Mar 13;95(1):41. doi: 10.1007/s00280-025-04749-w. Cancer Chemother Pharmacol. 2025. Retraction in: Cancer Chemother Pharmacol. 2025 Jul 25;95(1):77. doi: 10.1007/s00280-025-04798-1. PMID: 40075030 Free PMC article. Retracted. Review.
• Folic acid and folinic acid for reducing side effects in patients receiving methotrexate for rheumatoid arthritis.

  Shea B, Swinden MV, Ghogomu ET, Ortiz Z, Katchamart W, Rader T, Bombardier C, Wells GA, Tugwell P. Shea B, et al. J Rheumatol. 2014 Jun;41(6):1049-60. doi: 10.3899/jrheum.130738. Epub 2014 Apr 15. J Rheumatol. 2014. PMID: 24737913
• Folic acid and folinic acid for reducing side effects in patients receiving methotrexate for rheumatoid arthritis.

  Shea B, Swinden MV, Tanjong Ghogomu E, Ortiz Z, Katchamart W, Rader T, Bombardier C, Wells GA, Tugwell P. Shea B, et al. Cochrane Database Syst Rev. 2013 May 31;2013(5):CD000951. doi: 10.1002/14651858.CD000951.pub2. Cochrane Database Syst Rev. 2013. PMID: 23728635 Free PMC article.
• Folic acid and folinic acid for reducing side effects in patients receiving methotrexate for rheumatoid arthritis.

  Ortiz Z, Shea B, Suarez Almazor M, Moher D, Wells G, Tugwell P. Ortiz Z, et al. Cochrane Database Syst Rev. 2000;(2):CD000951. doi: 10.1002/14651858.CD000951. Cochrane Database Syst Rev. 2000. Update in: Cochrane Database Syst Rev. 2013 May 31;(5):CD000951. doi: 10.1002/14651858.CD000951.pub2. PMID: 10796393 Updated.
• Effect of folic or folinic acid supplementation on methotrexate-associated safety and efficacy in inflammatory disease: a systematic review.

  Prey S, Paul C. Prey S, et al. Br J Dermatol. 2009 Mar;160(3):622-8. doi: 10.1111/j.1365-2133.2008.08876.x. Epub 2008 Oct 20. Br J Dermatol. 2009. PMID: 18945303